Bridgetech Opens Taiwan Office
Share:
Formosa Biomedical Technology CEO and Taipei Mayor Join Bridgetech at Grand Opening Celebration
SAN DIEGO, Aug. 13 /-- Bridgetech Holdings International Inc. (BULLETIN BOARD: BGTH.PK) , a company focused on maximizing the potential of emerging healthcare products and services in the U.S. and Asian markets, today announced that it has successfully opened its Taiwan branch office in Taipei -- Bridgetech Medicines Limited (BML). The highly anticipated grand opening included Formosa Biomedical Technology CEO Wang Jui-yu, Taipei Mayor Hau Lung-bin, National Health Research Institutes (NHRI) director Jacqueline Whang-Peng, and members of Ministry of Economic Affairs (MOEA).
"The value of the Taiwan market is tremendous," stated Michael Chermak, Chairman and CEO of Bridgetech. "The alliances with Taiwan's governmental bodies, medical research institutes, medical providers and leading companies like Formosa are allowing the company to quickly ramp up our technology transfer initiatives."
John Chen, President of Bridgetech Medicines Limited, added "We're pleased to bring CellSearch to Taiwan's oncology market. In addition, Bridgetech's base in Taiwan allows an ongoing evaluation and introduction of current and future products in our pipeline."
About Bridgetech Holdings International, Inc.
Bridgetech is leveraging its extensive network of relationships in China and the U.S. to capitalize on the demand for Western healthcare in Greater China. The company is bringing emerging drugs, devices and diagnostics to Greater China, with an initial focus on oncology. For additional information, please visit Bridgetech at www.bthi.com/ .
Bridgetech Medicines LimitedRoom WR05., 17th floor, 3 YuanQu St., Taipei
115, Taiwan
Tel: 02-2653-9013
Fax: 02-2653-8047
FCMN Contact: dme@behmedia.com
Source: Bridgetech Holdings International Inc.
Web site: www.bthi.com/
